Navigation Links
Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
Date:10/14/2008

VINELAND, ON, Oct. 14 /PRNewswire/ - Vineland Research and Innovation Centre, an independent, not-for-profit corporation established to create a world-class centre for horticultural science and innovation in Ontario, today announced the appointment of Dr. Daryl Somers to the new role of Research Chair, Molecular Breeding and Biotechnology for the Centre.

"Vineland is determined to become a beacon of sustainability, original research, and practical application," said Dr. Jim Brandle, C.E.O., Vineland Research and Innovation Centre. "We are very pleased Dr. Somers will be joining us as his expertise will help us achieve our vision and allow us to make meaningful contributions in the advancement of translational research as we work toward a future with innovative horticultural crops that have added value and reduced environmental impact."

As the Research Chair, Molecular Breeding and Biotechnology at Vineland, Dr. Somers will focus on research initiatives that support the application of leading-edge genomics and breeding to improve horticultural crops.

Dr. Somers brings a wealth of experience to Vineland, including expertise in the use of DNA markers, high-throughput genotyping in large multi-species breeding programs. Prior to joining Vineland, Dr. Somers was a senior Research Scientist of Molecular Genetics, Bioproducts and Bioprocesses at Agriculture and Agri-Food Canada's Cereal Research Centre in Winnipeg, MB.

Dr. Somers' previous experience includes Research Geneticist at the University of Missouri; Research Geneticist at Washington State University; and Research Scientist at the Molecular Genetics Section of Agriculture and Agri-Food Canada's Saskatoon Research Centre. Dr. Somers earned a B.Sc. (Honors) in cell biology and genetics, and a Masters of Science in Botany and a Ph.D. in Botany from the University of Toronto.

About Vineland Research and Innovation Centre

Located in the Niagara Region, Vineland Research and Innovation Centre is a not-for-profit corporation. As result of a government, academic and industry-led initiative, Vineland is working to become a world-class research institution and international centre for horticulture and ornamentals research, innovation and commercialization.

Founded in 1906 through a gift by M. F. Rittenhouse, the Vineland Research Station has contributed to the emergence of a competitive horticulture industry in one of Canada's most unique geographic regions. It is accredited with the development and release of over 150 new varieties of fruits, vegetables and ornamental plants, as well as numerous production techniques and post-harvest technologies.


'/>"/>
SOURCE Vineland Research and Innovation Centre
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
2. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
3. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
4. FCP Welcomes Mark Scherling
5. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
6. Piedmont Heart Institute Welcomes Cardiology of Georgia
7. Aegera Therapeutics welcomes two experienced executives to its board of directors
8. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
9. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
10. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
11. Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):